新西兰年轻与年长人群心力衰竭发病率趋势分化(2006-2018)
该全国性数据链接研究利用常规住院数据识别2006-2018年新西兰≥20岁居民116 113例次新发心衰住院,计算年龄别与年龄标化发病率并用Joinpoint回归比较趋势。年龄标化发病率2006-2013年下降后于2013-2018年趋于平台,20-49岁人群发病率每年上升,≥80岁人群持续下降。
要点
- 年龄标化心衰发病率2006-2013年下降,2013-2018年趋于平台
- 20-49岁人群心衰发病率每年上升1.5%,≥80岁人群每年下降1.2%
- 缺血性心脏病相关心衰住院占比由2006年35.1%降至2018年28.0%
核心结论
- 新西兰心衰仍是重要问题,整体发病率下降自2013年起趋于平台,源于年轻年龄组发病率上升而老年人群持续下降。
- 2006-2018年20-49岁人群心衰发病率每年上升1.5%(95%CI 0.3至2.7%),≥80岁人群每年下降1.2%(95%CI -1.7至-0.7%)。
研究设计与样本
- 全国性数据链接研究,使用常规收集的住院数据识别2006-2018年新西兰≥20岁居民新发心衰住院。
- 共识别116 113例次新发心衰住院,覆盖13年研究期。
- 按日历年计算年龄别与年龄标化发病率,并用Joinpoint回归比较趋势。
主要发现
- 年龄标化发病率由2006年403/10万降至2013年323/10万(年度百分比变化APC -2.6%,95%CI -3.6至-1.6%)。
- 2013-2018年年龄标化发病率趋于平台(APC 0.8%,95%CI -0.8至2.5%)。
- 50-79岁人群发病率2006-2013年 initially 下降,2013-2018年保持稳定或上升。
- 缺血性心脏病相关心衰住院占比由2006年35.1%降至2018年28.0%。
临床怎么用
- 应关注年轻人群(20-49岁)心衰发病率上升趋势,针对该年龄段加强风险评估与早期识别。
- 老年人群心衰发病率持续下降,但整体发病率下降已停滞,需维持并强化现有防控措施。
- 缺血性心脏病相关心衰占比下降,提示需关注非缺血性病因在年轻心衰患者中的作用。
局限性
- 研究仅基于常规住院数据识别心衰,可能受编码与就诊行为影响。
- 原文未报告门诊心衰或未住院病例,可能低估真实发病率。
- 原文未报告心衰亚型、病因分类及人群族裔等分层信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Studies indicate that age-standardised heart failure (HF) incidence has been decreasing internationally; however, contrasting trends in different age groups have been reported, with rates increasing in younger people and decreasing in the elderly. We aimed to describe age-specific trends in HF incidence in New Zealand (NZ). METHODS: In this nationwide data linkage study, we used routinely collected hospitalisation data to identify incident HF hospitalisations in NZ residents aged ≥20 years between 2006 and 2018. Age-specific and age-standardised incidence rates were calculated for each calendar year. Joinpoint regression was used to compare incidence trends. RESULTS: 116 113 incident HF hospitalisations were identified over the 13-year study period. Between 2006 and 2013, age-standardised incidence decreased from 403 to 323 per 100 000 (annual percentage change (APC) -2.6%, 95% CI -3.6 to -1.6%). This reduction then plateaued between 2013 and 2018 (APC 0.8%, 95% CI -0.8 to 2.5%). Between 2006 and 2018, rates in individuals aged 20-49 years old increased by 1.5% per year (95% CI 0.3 to 2.7%) and decreased in those aged ≥80 years old by 1.2% per year (95% CI -1.7 to -0.7%). Rates in individuals aged 50-79 years old initially declined from 2006 to 2013, and then remained stable or increased from 2013 to 2018. The proportion of HF hospitalisations associated with ischaemic heart disease decreased from 35.1% in 2006 to 28.0% in 2018. CONCLUSION: HF remains an important problem in NZ. The decline in overall incidence has plateaued since 2013 due to increasing rates of HF in younger age groups despite an ongoing decline in the elderly.
引用
- Chan DZL, Kerr A, Grey C, et al. Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006-2018. Heart. 2021. PMID: 34686566. doi:10.1136/heartjnl-2021-319853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。